SARS-CoV-2 causes viral pneumonia. The initial symptoms of patients are mostly fever, dry cough, and severe symptoms such as the gradual appearance of dysnea. Most patients have a good prognosis, and some severe cases may develop acute respiratory distress syndrome or septic shock, or even death. We have carried out a series of product development for different groups (suspected patients, recovered patients, and vaccinated healthy people) and at different stages (initial infection, infection period, recovery period, and after vaccination).
SARS-CoV-2 IVD covers the detection of SARS-CoV-2 antigen, SARS-CoV-2 IgG / IgM antibody, and SARS-CoV-2 neutralizing antibody. The principle of lateral-flow immunochromatography is applied, the test kit can be used for rapid, convenient and accurate detection.
Message submitted successfully !